Knowledge Center
Article / Feb 01, 2015
The Time Has Come
Source:
PMPS, 2015, February, pp. 30 - 33
The respiratory drug sector is experiencing a surge of interest as companies seek to capitalise on the rapidly growing market.
With new product launches and novel formulation combinations in development, inhaled drug delivery is reaching far beyond its origins in asthma and COPD treatments.
Related links
Also in the Knowledge Center
Scientific Article
/ Jan 01, 2014
Experimental design for the optimization and robustness testing of a liquid chromatography tandem mass spectrometry method for the trace analysis of the potentially genotoxic 1,3-diisopropylurea
Read more
Scientific Article
/ Jan 01, 2013
Environmental and economic analysis for selection and engineering sustainable API degenotoxification processes
Read more
Scientific Article